Sarepta Therapeutics, Inc.(SRPT)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
SRPT | 2.43 B | -14.55x | -34.30% | -6.93% | $-1.58 | -9.48% | 0.70 | - | $25.32 | $14.68 |
FOLD | - | - | - | - | - | - | - | - | - | - |
VRTX | 141.42 B | 32.33x | 12.50% | 35.00% | $17.26 | 23.54% | 9.77 | - | $555.69 | $374.17 |
ALNY | 35.39 B | 45.45x | 66.90% | 16.13% | $5.82 | 96.56% | 2.21 | - | $495.55 | $197.81 |
INSM | 27.66 B | -29.88x | 2.96% | -76.94% | $-4.24 | -87.22% | 0.98 | - | $212.75 | $90.39 |
CRSP | 5.46 B | -12.15x | 10.41% | - | $-4.65 | -26.10% | 0.45 | - | $78.48 | $44.12 |
Peer Valuation & Performance Analysis
Peer group analysis for Sarepta Therapeutics, Inc. (SRPT) compared to its primary competitors (including FOLD, VRTX, ALNY) reveals distinct metrics. SRPT trades at a valuation discount relative to its competitors, with a P/E ratio of -14.6x versus the peer average of 6.4x (representing a 328% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, SRPT's revenue growth of -34.3% lags behind the peer average of 9.3%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -6.9% is comparable to the peer average of -8.6%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• SRPT ranks #0 in P/E ratio, #5 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $23.15 | $23.34 | $22.42 | $22.99 | 2,768,100 | -0.69% |
| 2026-09-02 | $21.33 | $23.62 | $21.33 | $23.21 | 4,806,600 | +8.81% |
| 2026-09-01 | $20.88 | $21.82 | $20.55 | $21.33 | 2,623,500 | +2.16% |
| 2026-08-31 | $20.56 | $21.16 | $20.18 | $21.03 | 2,656,600 | +2.29% |
| 2026-08-28 | $21.49 | $22.58 | $20.83 | $20.86 | 3,612,200 | -2.93% |
| 2026-08-27 | $19.35 | $22.59 | $18.77 | $21.59 | 7,918,700 | +11.58% |
| 2026-08-26 | $18.74 | $19.48 | $18.31 | $19.46 | 2,409,600 | +3.84% |
| 2026-08-25 | $18.42 | $19.05 | $18.19 | $18.92 | 1,696,200 | +2.71% |
| 2026-08-24 | $18.53 | $18.71 | $17.90 | $18.13 | 1,380,900 | -2.16% |
| 2026-08-21 | $19.39 | $19.73 | $18.66 | $18.79 | 1,674,600 | -3.09% |
| 2026-08-20 | $19.42 | $19.95 | $18.59 | $19.22 | 2,913,400 | -1.03% |
| 2026-08-19 | $18.74 | $20.19 | $18.74 | $19.73 | 4,941,900 | +5.28% |
| 2026-08-18 | $18.17 | $18.29 | $17.88 | $18.02 | 1,599,700 | -0.83% |
| 2026-08-17 | $17.93 | $18.30 | $17.72 | $18.18 | 1,728,600 | +1.39% |
| 2026-08-14 | $18.22 | $18.26 | $17.69 | $18.10 | 1,561,000 | -0.66% |
Explore More Analysis for SRPT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.